PSMA PET in Staging Prostate Cancer I Clinical Nuclear Medicine

3 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Peptide-specific membrane antigen (PSMA) PET has revolutionized the staging of prostate cancer by providing superior sensitivity and specificity for detecting nodal and distant metastases. This academic lecture discusses the role of PSMA PET in the initial staging of prostate cancer, imaging protocols, interpretation, clinical indications, pitfalls, and its impact on patient management.

Presenter: Dr Julie Hephzibah, Professor and Head, Department of Nuclear Medicine, Christian Medical College Vellore

This lecture is intended for:

Nuclear Medicine residents
DNB/MD Nuclear Medicine trainees
Radiology residents
Urology trainees
Medical oncologists
Radiation oncologists
Medical students

Topics Covered
• Biology of PSMA
• Indications for PSMA PET in initial staging
• Imaging protocol and interpretation
• TNM staging with PSMA PET
• Detection of nodal and distant metastases
• Common pitfalls and physiological uptake
• Clinical impact on patient management
• Current guidelines and evidence

Subscribe to Nuclear Medicine Academics for academic lectures, case discussions, and updates in Nuclear Medicine.

#PSMAPET #ProstateCancer #NuclearMedicine #PETCT #Theranostics #Oncology #MolecularImaging #CMCVellore #NuclearMedicineAcademics #DNBNuclearMedicine #MDNuclearMedicine #Urology #Radiology
Categoria
Urology
Commenta per primo questo video.

Prossimo